neurology – Medxy AI

Genetic Breakthrough: How SNUPN Gene Variants Lead to Spinocerebellar Atrophy

By MedXY 03/06/2026

Researchers have discovered that mutations in the SNUPN gene cause spinocerebellar atrophy by disrupting RNA splicing in Purkinje cells, expanding the understanding of neurodevelopmental disorders beyond muscular conditions.

Neurology news

Antiepileptogenesis After Stroke: Assessing the Impact of Eslicarbazepine Acetate on Seizure Prevention

By MedXY 03/06/2026

This article examines a Phase 2a trial investigating eslicarbazepine acetate for preventing post-stroke epilepsy. While the primary endpoint was not met due to recruitment challenges, the study provides a critical framework for future antiepileptogenic research in high-risk stroke populations.

Internal Medicine Neurology news

Minocycline Significantly Improves Functional Recovery in Acute Ischaemic Stroke: Evidence from the EMPHASIS Trial

By MedXY 02/25/2026

The EMPHASIS trial reveals that oral minocycline initiated within 72 hours of an acute ischaemic stroke significantly enhances functional independence at 90 days. This multicentre study provides robust evidence for a well-tolerated, accessible neuroprotective strategy beyond the traditional reperfusion window.

Neurology news Pediatrics

AAV9 Gene Therapy Shows Clinical Promise in Stabilizing Type II GM1 Gangliosidosis

By MedXY 02/23/2026

A Phase 1-2 trial of AAV9-GLB1 gene therapy in children with Type II GM1 gangliosidosis demonstrates significant biochemical improvements and stabilization of neurodevelopmental decline, marking a pivotal step toward treating this fatal lysosomal storage disorder.

Internal Medicine Neurology news

Predicting the Path to Dementia: Five-Year Progression from Mild to Major Vascular Cognitive Impairment Following Ischemic Stroke

By MedXY 02/17/2026

A five-year prospective study reveals that 13.6% of stroke patients with mild cognitive impairment progress to major VCI, identifying age, diabetes, atrial fibrillation, and small vessel disease as key predictors for long-term cognitive decline.

Neurology news Public Health

Moderate Caffeinated Coffee and Tea Intake Linked to 18% Lower Dementia Risk in Decades-Long Study

By MedXY 02/10/2026

A prospective study of over 130,000 adults reveals that consuming 2-3 cups of caffeinated coffee or 1-2 cups of tea daily significantly reduces dementia risk and cognitive decline, whereas decaffeinated coffee shows no protective effect.

Neurology news Orthopedics

Restoring Movement: How Polylaminin is Revolutionizing Spinal Cord Injury Treatment

By MedXY 02/07/2026

Brazilian scientists have developed Polylaminin, a protein derived from human placenta that stimulates nerve regeneration. In early trials, six paralyzed patients regained the ability to walk, prompting official Phase I clinical trials to begin this year.

Neurology news Radiology

Apixaban Shows No Increased Risk of MRI-Detected Intracranial Hemorrhage Compared to Aspirin in Atrial Cardiopathy

By MedXY 02/05/2026

An exploratory analysis from the ARCADIA-MRI substudy reveals that apixaban carries a similar risk of incident intracranial hemorrhages, microbleeds, and superficial siderosis compared to aspirin in patients with atrial cardiopathy and cryptogenic stroke.

Cardiology Neurology news

Predicting Stroke Recurrence: MRI Markers Outperform Location in Risk-Stratifying Patients with ICH and Atrial Fibrillation

By MedXY 01/21/2026

A secondary analysis of the PRESTIGE-AF trial reveals that specific MRI markers, including cortical superficial siderosis and macrohemorrhages, are more potent predictors of recurrent intracerebral hemorrhage than hematoma location alone, offering a path toward individualized anticoagulation strategies.

Neurology news Radiology

Medical Management Proves Superior to Endovascular Recanalization for Symptomatic Nonacute Intracranial Artery Occlusion

By MedXY 01/06/2026

A multicenter cohort study (ERNA-IAO) demonstrates that endovascular recanalization significantly increases the risk of stroke and death compared to medical treatment alone in patients with symptomatic nonacute intracranial artery occlusion, primarily due to high perioperative complication rates.

Neurology news Psychiatry

A Global Standard: Understanding the New VasCog-2-WSO Criteria for Vascular Dementia

By MedXY 01/02/2026

Experts have released the VasCog-2-WSO criteria, an updated international standard for diagnosing vascular cognitive impairment and dementia. This revision introduces a preclinical stage and incorporates modern neuroimaging and fluid biomarkers to improve diagnostic consistency across global clinical and research settings.

Neurology news

The Smart Thermostat for the Brain: How Adaptive DBS is Redefining Parkinson’s Treatment

By MedXY 01/02/2026

A groundbreaking clinical trial reveals that adaptive deep brain stimulation (aDBS) provides a safer, more efficient, and personalized way to manage Parkinson’s disease symptoms by responding to real-time brain activity.

Neurology news

Candesartan 16 mg Emerges as a Robust, Evidence-Based Option for Migraine Prophylaxis

By MedXY 12/23/2025

A Phase 2 triple-blind trial confirms that 16 mg of candesartan daily significantly reduces monthly migraine days compared to placebo, offering a well-tolerated oral alternative for patients with episodic migraine.

Infectious Diseases Neurology news

The SEIZURE Score Faces Global Challenges: International Validation Highlights Geographic Disparities in Predicting Encephalitis Seizures

By MedXY 12/18/2025

An international evaluation of the SEIZURE score reveals limited global predictive power for acute seizures in encephalitis. While the tool performs well in Western Europe, particularly Portugal, its utility elsewhere is hampered by etiological diversity and diagnostic limitations.

Neurology news Otorhinolaryngology

Your Nose Knows: How Smell Loss Signals More Than a Cold — Links to 139 Diseases and What to Do About It

By MedXY 12/13/2025

A large prospective study links smell disturbances to at least 139 conditions. Olfactory loss can be an early sign of neurological, ENT, metabolic, or systemic disease — and a practical, underused screening tool clinicians can adopt.

Neurology news

Long-Term Seizure Outcomes and Epilepsy Risk in Anti-LGI1 Encephalitis: Insights from a Multicenter Cohort Study

By MedXY 10/23/2025

This study assesses seizure remission and epilepsy risk in 236 anti-LGI1 encephalitis patients, highlighting immunotherapy's role in seizure control and identifying biomarkers linked to persistent cognitive impairment and long-term outcomes.

Neurology Specialties

Early Intravenous Immunoglobulin Therapy Improves Long-Term Outcomes in Anti-IgLON5 Disease

By MedXY 10/22/2025

This retrospective multicenter study found that early intravenous immunoglobulin treatment in anti-IgLON5 disease is linked to reduced disability and mortality, highlighting a promising immunotherapeutic strategy for this rare autoimmune encephalopathy.

Clinical Updates Infectious Diseases Medical News Pediatrics Respiratory Specialties

Influenza-Associated Acute Necrotizing Encephalopathy in US Children

By MedXY 07/30/2025

A multicenter US study highlights the devastating burden of influenza-associated acute necrotizing encephalopathy in children, with high mortality and disability rates despite aggressive therapy, underscoring the urgent need for prevention and standardized management.